SCYNEXIS, Inc. Peo Actually Paid Comp Amt
SCYNEXIS, Inc. (SCYX) reported Peo Actually Paid Comp Amt of $947.17 thousand for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-30.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:PeoActuallyPaidCompAmt · last filed 2026-04-30
| Period end | Peo Actually Paid Comp Amt 12 month |
|---|---|
| 2025-12-31 | $947.17K DEF 14A · filed 2026-04-30 |
| 2024-12-31 | $1.43M DEF 14A · filed 2026-04-30 |
| 2023-12-31 | $1.49M DEF 14A · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |